These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26362194)

  • 1. Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii.
    Tan A; Stewart CJ; Garrett KL; Rye M; Cohen PA
    Endocr Pathol; 2015 Dec; 26(4):296-301. PubMed ID: 26362194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular variant papillary thyroid carcinoma arising in struma ovarii.
    Boutross-Tadross O; Saleh R; Asa SL
    Endocr Pathol; 2007; 18(3):182-6. PubMed ID: 18058267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF in papillary thyroid carcinoma of ovary (struma ovarii).
    Schmidt J; Derr V; Heinrich MC; Crum CP; Fletcher JA; Corless CL; Nosé V
    Am J Surg Pathol; 2007 Sep; 31(9):1337-43. PubMed ID: 17721188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii.
    Coyne C; Nikiforov YE
    Endocr Pathol; 2010 Jun; 21(2):144-7. PubMed ID: 19898969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF T1799A mutation occurring in a case of malignant struma ovarii.
    Flavin R; Smyth P; Crotty P; Finn S; Cahill S; Denning K; Jinghuan Li ; O'Regan E; O'Leary J; Sheils O
    Int J Surg Pathol; 2007 Apr; 15(2):116-20. PubMed ID: 17478764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
    Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
    Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unilateral follicular variant of papillary thyroid carcinoma with unique KRAS mutation in struma ovarii in bilateral ovarian teratoma: a rare case report.
    Stanojevic B; Dzodic R; Saenko V; Milovanovic Z; Krstevski V; Radlovic P; Buta M; Rulic B; Todorovic L; Dimitrijevic B; Yamashita S
    BMC Cancer; 2012 Jun; 12():224. PubMed ID: 22682753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations.
    Poli R; Scatolini M; Grosso E; Maletta F; Gallo M; Liscia D; Nelva A; Cesario F; Forte G; Metovic J; Volante M; Arvat E; Papotti M
    Endocrine; 2021 Jan; 71(1):216-224. PubMed ID: 32743766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
    Roth LM; Miller AW; Talerman A
    Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of Struma Ovarii: A Report of 96 Cases.
    Wei S; Baloch ZW; LiVolsi VA
    Endocr Pathol; 2015 Dec; 26(4):342-8. PubMed ID: 26374222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma.
    Leong A; Roche PJ; Paliouras M; Rochon L; Trifiro M; Tamilia M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4599-605. PubMed ID: 24217901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial on: Role of gene sequencing in classifying struma ovarii: BRAF P.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
    McCluggage WG
    Histopathology; 2024 Jan; 84(2):288-290. PubMed ID: 38110823
    [No Abstract]   [Full Text] [Related]  

  • 13. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases.
    Devaney K; Snyder R; Norris HJ; Tavassoli FA
    Int J Gynecol Pathol; 1993 Oct; 12(4):333-43. PubMed ID: 8253550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Struma Ovarii With Malignant Transformation and Germline KIT Mutation: A Case Report With Review of the Literature.
    Ma D; Guseva NV; Dahmoush L; Robinson RA
    Int J Gynecol Pathol; 2016 Sep; 35(5):442-7. PubMed ID: 27258816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary thyroid cancer in a struma ovarii: a report of a rare case.
    Monti E; Mortara L; Zupo S; Dono M; Minuto F; Truini M; Naseri M; Giusti M
    Hormones (Athens); 2015; 14(1):154-9. PubMed ID: 25402391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It Does Exist! Diagnosis and Management of Thyroid Carcinomas Originating in Struma Ovarii.
    Smith LP; Brubaker LW; Wolsky RJ
    Surg Pathol Clin; 2023 Mar; 16(1):75-86. PubMed ID: 36739168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci.
    Seo GT; Minkowitz J; Kapustin DA; Fan J; Minkowitz G; Minkowitz M; Dowling E; Matloob A; Asti D; Dhar M; Shutty C; Brickman A; Urken ML; Brandwein-Weber M; Finkelstein SD
    Diagn Pathol; 2023 Apr; 18(1):47. PubMed ID: 37072862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea.
    Kim M; Jeon MJ; Oh HS; Park S; Kim TY; Shong YK; Kim WB; Kim K; Kim WG; Song DE
    Thyroid; 2018 Apr; 28(4):504-510. PubMed ID: 29439609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.
    Anastasilakis AD; Ruggeri RM; Polyzos SA; Makras P; Molyva D; Campennì A; Gkiomisi A; Balaris C; Fotiadis PP; Tuccari G; Papachatzopoulos S
    Metabolism; 2013 Oct; 62(10):1350-6. PubMed ID: 23806737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant struma ovarii with thyroid-type papillary and poorly differentiated carcinoma: a case report.
    Terayama N; Fujiwara S; Ueda S; Yamada T; Ohmichi M
    J Med Case Rep; 2022 Sep; 16(1):348. PubMed ID: 36176008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.